1217459-13-6
1217459-13-6
Chemical Structure
3,3'-Diiodo-L-thyronine-13C6
Synonym(s): 3,3'-T2-13C6
- CAS No.: 1217459-13-6
- Formula:C913C6H13I2NO4
- Molecular Weight:531.03
IUPAC Name: (S)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy-1,2,3,4,5,6-13C6)-3-iodophenyl)propanoic acid
InChIKey: CPCJBZABTUOGNM-USQDWSSZSA-N
SMILES: IC(C=C(C=C1)C[C@H](N)C(O)=O)=C1O[13C]2=[13CH][13C](I)=[13C]([13CH]=[13CH]2)O
Biological Activity: 3,3'-Diiodo-L-thyronine-13C6 is the 13C labeled 3,3'-Diiodo-L-thyronine[1]. 3,3'-Diiodo-L-thyronine (3,3'-T2) is an endogenous metabolite of thyroid hormone. 3,3'-Diiodo-L-thyronine significantly enhances COX activity[2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3,3'-Diiodo-L-thyronine-13C6 | 3,3'-Diiodo-L-thyronine-13C6 is the 13C labeled 3,3'-Diiodo-L-thyronine. 3,3'-Diiodo-L-thyronine (3,3'-T2) is an endogenous metabolite of thyroid hormone. 3,3'-Diiodo-L-thyronine significantly enhances COX activity. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,3'-Diiodo-L-thyronine (Standard) | 95.29% | 3,3'-Diiodo-L-thyronine (Standard) is the analytical standard of 3,3'-Diiodo-L-thyronine. This product is intended for research and analytical applications. 3,3'-Diiodo-L-thyronine (3,3'-T2) is an endogenous metabolite of thyroid hormone. 3,3'-Diiodo-L-thyronine significantly enhances COX activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3,3'-Diiodo-L-thyronine | 96.33% | 3,3'-Diiodo-L-thyronine (3,3'-T2) is an endogenous metabolite of thyroid hormone. 3,3'-Diiodo-L-thyronine significantly enhances COX activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. Lorenzini L, et al. Assay of Endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3'-diiodo-L-thyronine (3,3'-T2) in Human Serum: A Feasibility Study. Front Endocrinol (Lausanne). 2019 Feb 19;10:88. [Content Brief]
- [3]. Lanni A, et al. Rapid stimulation in vitro of rat liver cytochrome oxidase activity by 3,5-diiodo-L-thyronine and by 3,3'-diiodo-L-thyronine. Mol Cell Endocrinol. 1994 Feb99(1):89-94. [Content Brief]
